PSMD2 and lung adenocarcinoma: In addition, abnormal expression of PSMD2 (proteasome 26S subunit ubiquitin receptor, non-ATPase 2), a subunit of the 19S regulatory particle (RP) of the proteasome, has been reported in lung adenocarcinoma, breast cancer, and hepatocellular carcinoma [24–26].